Matches in Wikidata for { <http://www.wikidata.org/entity/Q99530245> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q99530245 description "clinical trial" @default.
- Q99530245 description "ensayo clínico" @default.
- Q99530245 description "ensayu clínicu" @default.
- Q99530245 description "klinisch onderzoek" @default.
- Q99530245 description "клінічне випробування" @default.
- Q99530245 description "临床试验" @default.
- Q99530245 name "A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients" @default.
- Q99530245 name "A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients" @default.
- Q99530245 type Item @default.
- Q99530245 label "A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients" @default.
- Q99530245 label "A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients" @default.
- Q99530245 prefLabel "A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients" @default.
- Q99530245 prefLabel "A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients" @default.
- Q99530245 P1050 Q99530245-3F81CDC2-E393-4AA7-9B93-C7F6B9270FA0 @default.
- Q99530245 P1132 Q99530245-D2A90E7B-B3D2-4619-AC2B-1FBA2C2F4BAC @default.
- Q99530245 P1476 Q99530245-246F9180-54AE-41AB-96C4-43C094A4F70F @default.
- Q99530245 P2899 Q99530245-42821E1A-7D7E-4393-91CC-0844DCAFD82B @default.
- Q99530245 P3098 Q99530245-54F7F812-49A5-4B88-9C85-953DEF0F961A @default.
- Q99530245 P31 Q99530245-2098F021-E54A-408F-A2E3-C39584EC211C @default.
- Q99530245 P4844 Q99530245-A224E14B-F38F-4281-83EE-5874641ED258 @default.
- Q99530245 P580 Q99530245-01119C2F-A40B-459D-91E2-6E89CB00EDCA @default.
- Q99530245 P582 Q99530245-3898E757-C0AB-4479-8A17-2CFD608E69F1 @default.
- Q99530245 P6099 Q99530245-29A98BD7-5A26-47A5-8A49-CF679EB2E525 @default.
- Q99530245 P8005 Q99530245-EEF88D40-823E-4E9A-8FA7-0F9D0725C617 @default.
- Q99530245 P8363 Q99530245-26C0E2C0-DFDE-4113-AA5B-ED4749702C49 @default.
- Q99530245 P1050 Q29496 @default.
- Q99530245 P1132 "+35" @default.
- Q99530245 P1476 "A Phase 1b Open-label Study to Investigate the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Adults With Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)" @default.
- Q99530245 P2899 "+18" @default.
- Q99530245 P3098 "NCT04521231" @default.
- Q99530245 P31 Q30612 @default.
- Q99530245 P4844 Q410189 @default.
- Q99530245 P580 "2020-10-14T00:00:00Z" @default.
- Q99530245 P582 "2023-02-14T00:00:00Z" @default.
- Q99530245 P6099 Q5452194 @default.
- Q99530245 P8005 Q76649614 @default.
- Q99530245 P8363 Q78089383 @default.